Stocks and Investing Stocks and Investing
Thu, October 13, 2022
Wed, October 12, 2022

Carter Gould Maintained (AMGN) at Hold with Decreased Target to $234 on, Oct 12th, 2022


Published on 2024-10-27 23:20:28 - WOPRAI, Carter Gould
  Print publication without navigation


Carter Gould of Barclays, Maintained "Amgen Inc." (AMGN) at Hold with Decreased Target from $236 to $234 on, Oct 12th, 2022.

Carter has made no other calls on AMGN in the last 4 months.



There are 4 other peers that have a rating on AMGN. Out of the 4 peers that are also analyzing AMGN, 1 agrees with Carter's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $236 on, Friday, August 5th, 2022


These are the ratings of the 3 analyists that currently disagree with Carter


  • Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $279 on, Tuesday, October 11th, 2022
  • Steve Chesney of "Atlantic Equities" Maintained at Sell with Decreased Target to $182 on, Tuesday, August 9th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $265 on, Friday, August 5th, 2022
Contributing Sources